Recruiting Myositis Studies in Chicago
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myop...
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy...
About Myositis Clinical Trials in Chicago
Myositis refers to inflammatory conditions causing muscle weakness and inflammation. Dermatomyositis also involves skin rashes, while polymyositis primarily affects muscles closest to the trunk. Treatment includes corticosteroids, immunosuppressants, and physical therapy.
There are currently 2 myositis clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 147 participants. Research is being sponsored by Novartis Pharmaceuticals, Cabaletta Bio. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myositis Clinical Trials in Chicago — FAQ
Are there myositis clinical trials in Chicago?
Yes, there are 2 myositis clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What myositis treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for myositis.
Data updated March 2, 2026 from ClinicalTrials.gov